Endocrine Therapy of Breast Cancer V
Seiten
1992
Springer Berlin (Hersteller)
978-3-540-55718-0 (ISBN)
Springer Berlin (Hersteller)
978-3-540-55718-0 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
A series of essays on the subject which includes material on the normal breast cell, the cancer cell, new endocrine treatments, mechanisms of resistance to therapeutic agents, the quality of life of a patient with breast cancer and other related public health issues.
Endocrine mechanisms and breast cancer continue to be important subjects for research in cancer medicine. This fifth volume of the ESO Task Force on the endocrine therapy of breast cancer provides the reader with an update of recent developments in the field. The spectrum of the items is remarkably broad and includes the normal breast cell, the cancer cell, mechanisms of resistance to therapeutic agents, new endocrine treatments, the patient with breast cancer, her quality of life, and some public health issues related to the population of women with the disease.
Endocrine mechanisms and breast cancer continue to be important subjects for research in cancer medicine. This fifth volume of the ESO Task Force on the endocrine therapy of breast cancer provides the reader with an update of recent developments in the field. The spectrum of the items is remarkably broad and includes the normal breast cell, the cancer cell, mechanisms of resistance to therapeutic agents, new endocrine treatments, the patient with breast cancer, her quality of life, and some public health issues related to the population of women with the disease.
Normal cell lineages and the phenotype of the breast cancer cell; the oestrogen-related pS2-BCEI protein in breast cancer; do all roads lead to the oestrogen receptor?; Tamoxifen for the treatment of breast cancer in the premenopausal patient; the multi-drug resistance phenotype and its reversal by drugs (with special emphasis on anti-oestrogens); new endocrine agents for breast cancer; prognostic factors in primary breast cancer - second thoughts; the contribution of perturbed epithelial-mesenchymal interactions to cancer pathogenesis; reporting results from adjuvant therapy trials with special emphasis on quality-of-life findings; adjuvant chemoendocrine therapies in pre-and post-menopausal breast cancer.
| Zusatzinfo | 33 figs., 20 tabs. |
|---|---|
| Verlagsort | Berlin |
| Sprache | englisch |
| Gewicht | 580 g |
| Einbandart | gebunden |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Gynäkologie / Geburtshilfe |
| Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| Studium ► 1. Studienabschnitt (Vorklinik) ► Histologie / Embryologie | |
| ISBN-10 | 3-540-55718-0 / 3540557180 |
| ISBN-13 | 978-3-540-55718-0 / 9783540557180 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
